ES2069742T3 - Proteina de la capsida del calicivirus felino y secuencia nucleotida. - Google Patents

Proteina de la capsida del calicivirus felino y secuencia nucleotida.

Info

Publication number
ES2069742T3
ES2069742T3 ES90911095T ES90911095T ES2069742T3 ES 2069742 T3 ES2069742 T3 ES 2069742T3 ES 90911095 T ES90911095 T ES 90911095T ES 90911095 T ES90911095 T ES 90911095T ES 2069742 T3 ES2069742 T3 ES 2069742T3
Authority
ES
Spain
Prior art keywords
protein
feline calicivirus
nucleotide sequence
calicivirus capsid
dna molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90911095T
Other languages
English (en)
Inventor
Richard C Wardley
Leonard Edwin Post
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2069742T3 publication Critical patent/ES2069742T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION PRESENTA MOLECULAS DE ADN RECOMBINANTES QUE CONTIENEN UNA SECUENCIA QUE CODIFICA UN POLIPEPTIDO DEL CALICIVIRUS DE LOS FELINOS, EN PARTICULAR LA PROTEINA CAPSIDA, CELULAS HUESPEDES TRANSFORMADAS POR DICHAS SECUENCIAS DE MOLECULAS DE ADN RECOMBINANTES Y LOS POLIPEPTIDOS CAPSIDICOS. LA PRESENTE INVENCION PRESENTA TAMBIEN VACUNAS SUBUNITARIAS Y VACUNAS MULTIVALENTES PARA EL FCV.
ES90911095T 1989-07-21 1990-07-09 Proteina de la capsida del calicivirus felino y secuencia nucleotida. Expired - Lifetime ES2069742T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38390989A 1989-07-21 1989-07-21
US40898989A 1989-09-18 1989-09-18

Publications (1)

Publication Number Publication Date
ES2069742T3 true ES2069742T3 (es) 1995-05-16

Family

ID=27010385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90911095T Expired - Lifetime ES2069742T3 (es) 1989-07-21 1990-07-09 Proteina de la capsida del calicivirus felino y secuencia nucleotida.

Country Status (9)

Country Link
EP (1) EP0484382B1 (es)
JP (1) JPH04506900A (es)
AT (1) ATE119545T1 (es)
AU (1) AU629381B2 (es)
CA (1) CA2055598C (es)
DE (1) DE69017687T2 (es)
DK (1) DK0484382T3 (es)
ES (1) ES2069742T3 (es)
WO (1) WO1991001332A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989561A (en) * 1991-03-07 1999-11-23 Virogenetics Corporation Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
CA2090515C (en) * 1992-02-28 2002-10-29 Kazuhiko Kimachi Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
ES2080023B1 (es) * 1994-07-08 1996-08-16 Iberica Cyanamid Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
FR2741806B1 (fr) * 1995-11-30 1998-02-20 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
FR2751223B1 (fr) * 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
US6231863B1 (en) 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
WO2000076538A1 (en) * 1999-06-10 2000-12-21 Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof
FR2796397B1 (fr) * 1999-07-16 2006-09-01 Merial Sas Genes de calicivirus felin et vaccins notamment vaccins recombines
US6541458B1 (en) 1999-07-16 2003-04-01 Merial Feline calicivirus genes and vaccines in particular recombinant vaccines
FR2796396A1 (fr) * 1999-07-16 2001-01-19 Merial Sas Gene de calicivirus felin et vaccin recombine les incorporant
FR2796282B1 (fr) * 1999-07-16 2001-10-26 Merial Sas Vaccin inactive contre la calicivirose feline
WO2005080416A1 (en) * 2004-01-20 2005-09-01 Pharmacia & Upjohn Company Llc Feline calicivirus vaccines
CN103550768B (zh) * 2005-07-28 2016-01-20 硕腾服务有限责任公司 疫苗施用方法、新猫杯状病毒、及抗猫细小病毒和猫疱疹病毒的动物免疫方法
EP3394085B1 (en) * 2015-12-23 2022-08-24 Intervet International B.V. Feline calicivirus vaccine
CN109207441B (zh) * 2018-08-12 2022-05-27 扬州大学 重组杆状病毒表达猪圆环病毒3型Cap蛋白及其构建方法与引物

Also Published As

Publication number Publication date
CA2055598A1 (en) 1991-01-22
AU629381B2 (en) 1992-10-01
WO1991001332A1 (en) 1991-02-07
AU6037990A (en) 1991-02-22
EP0484382A1 (en) 1992-05-13
ATE119545T1 (de) 1995-03-15
EP0484382B1 (en) 1995-03-08
DE69017687D1 (de) 1995-04-13
DE69017687T2 (de) 1995-10-19
DK0484382T3 (da) 1995-07-24
JPH04506900A (ja) 1992-12-03
CA2055598C (en) 1998-12-08

Similar Documents

Publication Publication Date Title
ES2069742T3 (es) Proteina de la capsida del calicivirus felino y secuencia nucleotida.
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
ES2127829T3 (es) Expresion de proteinas recombinantes fusionadas en bacterias atenuadas.
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
DK0640133T3 (da) Rekombinante DNA-molekyler, der koder for aminopeptidaseenzymer og deres anvendelse i fremstillingen af vacciner mod helmin
ES2165851T3 (es) Proteinas multivalentes que se unen a antigenos.
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
AR038568A1 (es) Anticuerpos anti-a beta y su uso
ES2170075T3 (es) Vacuna de proteina m recombinante multivalente.
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
BR7908410A (pt) Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos
ES2054701T3 (es) Clonacion y expresion de dna conteniendo el codigo de la toxina bordetella pertussis.
ES2103928T3 (es) Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis.
CO5560591A2 (es) Vacunas de adn optimizadas por el codon vih-gag
DK573783D0 (da) Gen,dna eller en underenhed heraf,som koder for human h2-preprorelaxin eller en underenhed deraf,fremgangsmaade til fremstilling af samme samt fremgangsmaade til fremstilling af human h2-preprorelaxin eller en underenhed deraf
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
DK0661999T3 (da) Vacciner mod felint immundefekt virus (FIV)
FI20070041A (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
FI961202A0 (fi) Grb3-3-geeni, sen variantteja ja niiden käyttöjä
PE20001287A1 (es) Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica con efecto antitumoral
ES2118242T3 (es) Vacunas anti virus de la inmunodeficiencia felina (fiv).
IT1249684B (it) Epitopi della proteina env del virus dell'epatite c.
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
ES2085163T3 (es) Vacunas contra los parasitos metazoos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 484382

Country of ref document: ES